Jeffrey Shealy is Former Chief Executive Officer of Aktis Oncology, Inc. (AKTS). The company reported total compensation of $1,290,740 for fiscal year 2023.
| Salary | $470,730 |
|---|---|
| Bonus | $0 |
| Stock awards | $571,500 |
| Option awards | $0 |
| Non-equity incentive plan | $235,365 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $13,145 |
| Total | $1,290,740 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Aktis Oncology, Inc. filed October 8, 2024, accession 0001213900-24-086050.
| Named executive officer | Role | FY2023 total |
|---|---|---|
| Jeffrey Shealy this page | Former Chief Executive Officer | $1,290,740 |
| David Aichele | Former EVP of Business Development | $787,872 |
| Kenneth Boller | Chief Financial Officer | $685,936 |
The company's named executive officers for fiscal year 2023, and what it reported for each. See the full Aktis Oncology, Inc. compensation brief.
Jeffrey Shealy's compensation sits inside Aktis Oncology, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.